MedPath
NMPA Approval

Salbutamol Sulfate Inhalation Aerosol

国药准字HJ20150673

September 18, 2023

H20150673

Drug Information

硫酸沙丁胺醇吸入气雾剂

万托林

吸入气雾剂

每瓶200揿,每揿含硫酸沙丁胺醇100μg(按C₁₃H₂₁NO₃计),递送剂量为硫酸沙丁胺醇90μg(按C₁₃H₂₁NO₃计)

化学药品

September 18, 2023

September 17, 2028

Company Information

Applicant Company

GLAXOSMITHKLINE SA

Severo Ochoa, 2, 28760 Tres Cantos (Madrid), Spain

Manufacturing Company

glaxo wellcome s.a.

Avda de Extremadura 3 09400 Aranda de Duero Burgos, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

硫酸沙丁胺醇吸入气雾剂 - NMPA 批准文号 | MedPath